PETX News
Archived Headlines
- Aratana Therapeutics decreases IPO price to $6 and increases shares offered 06/26/13
- Aratana Therapeutics postpones $51 million IPO 06/18/13
- 6 US IPOs planned for the week of Jun 17 06/17/13
- 3 US IPOs planned for the week of Jun 10 06/10/13
- US IPO Recap: IPO market continues torrid pace with six pricings, 12 new filers 05/28/13
See more
Paining cats and dogs: Nexvet sets terms for $58 million IPO
Nexvet, which is developing biologics for the treatment of pain and inflammation in cats and dogs, announced terms for its IPO on Monday. The Dublin, Ireland-based company plans to raise $58 million by offering 4.0 million shares at a price range of $13 to $16....read more
US IPO Recap: Market picks up the pace with ten IPOs, six price below the range
Deal flow picked up last week with ten IPOs pricing and raising almost $1.9 billion in proceeds. Though it was a strong week for pricings, six of the ten deals slashed...read more
All five IPOs price below original range on Wednesday, most in one day since June 1998
All five IPOs that priced on Wednesday had to slash their valuations in order to complete their offerings, as last week’s sell-off and concerns over market volatility forced companies to offer shares...read more
Aratana Therapeutics prices upsized IPO at $6 per share
Aratana Therapeutics, which is developing medications for cats and dogs based on therapies for humans, raised $35 million by offering 5.8 million shares, 250,000 more than anticipated, at $6, in line with the lower revised price. The company had previously...read more